Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -69.64%
March 31, 2026 -27.28%
December 31, 2025 97.21%
September 30, 2025 85.04%
June 30, 2025 41.92%
March 31, 2025 83.62%
December 31, 2024 54.05%
September 30, 2024 18.84%
June 30, 2024 82.48%
March 31, 2024 91.51%
December 31, 2023 68.97%
September 30, 2023 68.42%
June 30, 2023 85.57%
March 31, 2023 68.20%
December 31, 2022 56.48%
September 30, 2022 0.00%
June 30, 2022 0.00%
March 31, 2022 0.00%
Date Value
December 31, 2021 0.00%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 0.00%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
March 31, 2020 0.00%
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 0.00%
March 31, 2019 0.00%
December 31, 2018 0.00%
September 30, 2018 0.00%
June 30, 2018 0.00%
March 31, 2018 0.00%
December 31, 2017 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 55.20%
Akari Therapeutics Plc --
Cellectis SA 15.62%
DBV Technologies SA --
Oxford Biomedica Plc --

Gross Profit Margin (Quarterly) Related Metrics